Daphne van der Velden

4PUBLICATIONS
39CO-AUTHORS
Molecular targetsTumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 20, 2022
Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided Treatment.

Louisa R Hoes, Jade M van Berge Henegouwen, Hanneke van der Wijngaart

|Dec 30, 2021
Differential Survival and Therapy Benefit of Patients with Breast Cancer Are Characterized by Distinct Epithelial and Immune Cell Microenvironments.

Lennart Kester, Danielle Seinstra, Annelot G J van Rossum

|Oct 11, 2019
Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients.

Salo N Ooft, Fleur Weeber, Krijn K Dijkstra

|Jul 12, 2018
Detection of endogenously circulating mesenchymal stem cells in human cancer patients.

Daphne L van der Velden, Julia M Houthuijzen, Jeanine M L Roodhart

Pageof 1